BeOne Medicines AG
ONC
$335.17
$2.460.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.40B | 1.32B | 1.12B | 1.19B | 993.45M |
| Total Other Revenue | 17.27M | -- | -- | -- | 8.15M |
| Total Revenue | 1.41B | 1.32B | 1.12B | 1.19B | 1.00B |
| Cost of Revenue | 196.51M | 164.61M | 165.00M | 173.02M | 170.46M |
| Gross Profit | 1.22B | 1.15B | 952.28M | 1.02B | 831.14M |
| SG&A Expenses | 529.00M | 537.91M | 459.29M | 531.28M | 455.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -1.26M | -- |
| Total Operating Expenses | 1.25B | 1.23B | 1.11B | 1.26B | 1.12B |
| Operating Income | 163.11M | 87.89M | 11.10M | -75.01M | -120.27M |
| Income Before Tax | 147.16M | 99.55M | 20.90M | -65.63M | -98.30M |
| Income Tax Expenses | 22.32M | 5.23M | 19.63M | 74.06M | 23.05M |
| Earnings from Continuing Operations | 124.84M | 94.32M | 1.27M | -139.70M | -121.35M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 124.84M | 94.32M | 1.27M | -139.70M | -121.35M |
| EBIT | 163.11M | 87.89M | 11.10M | -75.01M | -120.27M |
| EBITDA | 198.86M | 117.75M | 42.73M | -33.25M | -50.16M |
| EPS Basic | 14.73 | 11.32 | 0.15 | -17.09 | -14.90 |
| Normalized Basic EPS | 0.91 | 0.59 | 0.13 | -0.38 | -0.58 |
| EPS Diluted | 13.52 | 10.14 | 0.15 | -17.09 | -15.21 |
| Normalized Diluted EPS | 0.88 | 0.57 | 0.13 | -0.38 | -0.58 |
| Average Basic Shares Outstanding | 110.22M | 108.32M | 106.93M | 106.26M | 105.90M |
| Average Diluted Shares Outstanding | 8.81M | 8.66M | 8.55M | 8.17M | 8.15M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |